STRS Ohio’s Treace Medical Concepts TMCI Stock Holding History

STRS Ohio’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,600	Closed	-$11.9K	–	2018
2024 Q4	$11.9K	Sell	1,600 -9,000	-85%	-$60.2K	﹤0.01%	1840
2024 Q3	$61.5K	Hold	10,600	–	–	﹤0.01%	1774
2024 Q2	$70.5K	Buy	+10,600	New	+$85.6K	﹤0.01%	1751
2023 Q3	–	Sell	-1,000	Closed	-$25K	–	2047
2023 Q2	$25K	Hold	1,000	–	–	﹤0.01%	1869
2023 Q1	$25K	Hold	1,000	–	–	﹤0.01%	1851
2022 Q4	$22K	Hold	1,000	–	–	﹤0.01%	1876
2022 Q3	$22K	Hold	1,000	–	–	﹤0.01%	1921
2022 Q2	$14K	Hold	1,000	–	–	﹤0.01%	1979
2022 Q1	$18K	Sell	1,000 -1,000	-50%	-$19.4K	﹤0.01%	2056
2021 Q4	$37K	Hold	2,000	–	–	﹤0.01%	2047
2021 Q3	$53K	Sell	2,000 -500	-20%	-$13.8K	﹤0.01%	2058
2021 Q2	$78K	Buy	+2,500	New	+$79.6K	﹤0.01%	2028

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

STRS Ohio's TMCI Position: Q1 2025 in Review

STRS Ohio sold out of Treace Medical Concepts (TMCI) in Q1 2025, closing a stake of 1,600 shares — an estimated $11.9K sold.

STRS Ohio first reported a position in TMCI in Q2 2021 and held it in 12 quarters. The position peaked at $78K in Q2 2021. 138 funds tracked by Wall St. Rank hold TMCI as of Q1 2025.

STRS Ohio reported no remaining Treace Medical Concepts position as of Q1 2025 after selling out during the quarter.
STRS Ohio sold 1,600 Treace Medical Concepts shares in Q1 2025, an estimated $11.9K.
STRS Ohio first reported a position in Treace Medical Concepts in Q2 2021 and held it in 12 quarters.
STRS Ohio's Treace Medical Concepts position peaked at $78K in Q2 2021.
138 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2025.

Based on STRS Ohio's 13F filing for Q1 2025, filed 28 May 2025.